gpc3 targeted therapeutics Gpc3 targeted therapeutic regimen is administered to the patient is effective

To determine the effectiveness of GPC3 targeted therapeutics therapy for cancer in a patient or the patient before undergoing GPC3 targeted therapeutic therapy or a method of determining the continuation of GPC3 targeted therapeutics therapy for patients, GPC3 targeted therapeutic agents It comprises monitoring the free GPC3 concentration of the patient and / or GPC3 targeted therapeutics therapy received biological sample isolated from a patient before undergoing therapy, if the free GPC3 concentration is a predetermined value the GPC3 targeted therapeutic therapy is determined to be valid, or, a method of determining the continuity of the GPC3 targeted therapeutic therapy is disclosed. Furthermore, GPC3 targeted therapeutic therapy is determined to be valid, or GPC3 targeted therapeutic agent or formulation to further administered to the patient it is decided to continue the GPC3 targeted therapeutic therapy are also disclosed.